Incidence of cutaneous adverse drug reactions among medical inpatients of Sultanah Aminah Hospital Johor Bahru
- Author:
Latha R Selvarajah
;
Siew Eng Choon
- Publication Type:Original Article
- Keywords:
Cutaneous adverse drug reaction;
inpatient;
incidence;
risk factors;
outcome
- From:
The Medical Journal of Malaysia
2017;72(3):151-156
- CountryMalaysia
- Language:English
-
Abstract:
Introduction: Cutaneous adverse drug reactions (cADRs)
are common. There are only few studies on the incidence of
cADRs in Malaysia.
Objective: To determine the incidence, clinical features and
risk factors of cADRs among hospitalized patients.
Methods:A prospective study was conducted among
medical inpatients from July to December 2014.
Results: A total of 43 cADRs were seen among 11 017
inpatients, yielding an incidence rate of 0.4%. cADR
accounted for hospitalization in 26 patients. Previous
history of cADR was present in 14 patients, with 50%
exposed to the same drug taken previously. Potentially lifethreatening
severe cutaneous adverse reactions (SCAR),
namely drug reaction with eosinophilia and systemic
symptoms (DRESS: 14 cases) and Stevens-Johnson
Syndrome/Toxic Epidermal Necrolysis (SJS/TEN: 6 cases)
comprise almost 50% of cADRs. The commonest culprit
drug group was antibiotics (37.2%), followed by
anticonvulsants (18.6%). Cotrimoxazole, phenytoin and
rifampicin were the main causative drugs for DRESS.
Anticonvulsants were most frequently implicated in
SJS/TEN (66.7%). Most cases had “probable” causality
relationship with suspected drug (69.8%). The majority of
cases were of moderate severity (65.1%), while 18.6% had
severe reaction with 1 death recorded. Most cases were not
preventable (76.7%). Older age (> 60 years) and mucosal
involvement were significantly associated with a more
severe reaction.
Conclusion: The incidence of cADRs was 0.4%, with most
cases classified as moderate severity and not preventable.
The commonest reaction pattern was DRESS, while the main
culprit drug group was antibiotics. Older age and mucosal
membrane involvement predicts a severe drug reaction.